Catalog Number 85000 |
Device Problems
Device Reprocessing Problem (1091); Nonstandard Device (1420); Delivered as Unsterile Product (1421)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 12/06/2016 |
Event Type
malfunction
|
Manufacturer Narrative
|
Even though the device is not available for evaluation, the label error has been identified and the associated lots placed on a global product hold.(b)(4) has been initiated and additional information will be added to this report, when available.Product is being used - only a label issue.
|
|
Event Description
|
It was reported by the quality officer that the non-sterile stent sizers were received in his department and that the outer label stated that the contents are sterile and not for reprocessing.
|
|
Manufacturer Narrative
|
The reported event could be confirmed with the pictures provided.The product was manufactured by stryker orthobiologics in malvern (usa).Therefore, the available complaint information was forwarded to the manufacturing site to review the related quality and manufacturing documents.The device history records (dhrs) for all medpor products packaged at millstone medical outsourcing were reviewed.The dhrs contain a sample of the labels printed for the corresponding lots.It was found that the label for eighteen lots of non-sterile products incorrectly contained symbols for sterile products.The complained device was not returned for investigation.However, images were provided that illustrate the incorrect label of the non-sterile product.On the lower part of the label a ¿sterile¿ symbol as well as symbols for ¿do not reuse¿ and ¿do not resterilize¿ are incorrectly present.Based on the investigation it can be clearly stated that the root cause of this complaint is manufacturing related and resulted from the operator millstone medical outsourcing (mmo) selecting the incorrect format during label generation; an nc was opened.A recall was conducted for the affected products.Part numbers were linked to specific label templates, correcting label specifications to reflect the correct template for the affected products and optimizing the process at mmo were implemented actions to eliminate the complaint root cause.The results from the capa effectiveness check are still pending and will be finalized on 2018-jan-17.The complaint is added to the complaint trend.Actual device not returned, but enough identification information was provided to perform a complete manufacturing/labeling review.
|
|
Event Description
|
It was reported by the quality officer that the non-sterile stent sizers were received in his department and that the outer label stated that the contents are sterile and not for reprocessing.
|
|
Search Alerts/Recalls
|